RMTI

Rockwell Medical, Inc. (DE) Common Stock NASDAQ Global Market
$1.87
Open: $1.93 High: $2.07 Low: $1.9 Close: $1.95
Range: 2022-05-18 - 2022-05-19
Volume:85,140
Market: Extended-hours
RMTI
Rockwell Medical, Inc. (DE) Common Stock 30142 WIXOM ROAD https://www.rockwellmed.com
Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States.
  • CEO: Stuart Paul
  • Employees: 300
  • Sector: Healthcare
  • Industry: Drug Manufacturers
Latest Stocks Posts
Card image
Card image
Card image
RMTI News
Latest news about the RMTI